Viropharma, Inc. (VPHM) –
-
Paulson's Paulson & Co. Shows New Stakes in CBS (CBS), Dollar General (DG), Verizon (VZ)
-
Paulson & Co Enters American Airlines (AAL), Extended Stay America (STAY), GM (GM) (more...)
-
Shire plc (SHPG) Completes ViroPharma (VPHM) Tender Offer
-
Viropharma, Inc. (VPHM) trading halted for info
-
Tractor Supply (TSCO) Set to Join the S&P 500; Align Technology (ALGN) to Join MidCap 400; Roadrunner Transportation (RRTS) and Boise Cascade (BCC) to Join S&P SmallCap 600
-
Annual Changes to the NASDAQ Biotechnology Index
-
Shire pic (SHPG) Said Antitrust Waiting Period for ViroPharma (VPHM) Deal Expires
-
Stifel Nicolaus Downgrades ViroPharma (VPHM) to Hold
-
Top 10 News for 11/11 - 11/15: Cisco Slammed on Outlook; Yellen's Okay with QE...for Now; Buffett's Big Energy Trade
-
ViroPharma (VPHM) Reports Statistically Significant Data from Cinryze Prophylaxis Study
-
JPMorgan Downgrades ViroPharma (VPHM) to Neutral
-
Market Wrap: Dow Jones at Another Record High; Shire's Pharma Purchase; Icahn, Transocean Settle
-
Unusual 11 Mid-Day Movers 11/11: (VISN) (GOGO) (VPHM) Higher; (ZLCS) (RDNT) (CRUS) Lower
-
Piper Jaffray Downgrades ViroPharma (VPHM) to Neutral
-
Shire (SHPG) Has Room for More Acquisitions Following ViroPharma (VPHM) Deal - Analyst
-
Notable Mergers and Acquisitions of the Day 11/11: (VPHM)/(SHPG) (GRFS)/(NVS) (RDA) (KKR)
-
Pre-Open Stock Movers 111/11: (VPHM) (GOGO) (DSCO) Higher; (CRUS) (EGHT) (IMGN) Lower (more...)
-
ViroPharma (VPHM) Peers on Watch Following Merger Deal (DYAX) (HALO)
-
Shire (SHPG) to Acquire ViroPharma (VPHM) in $4.2B Deal
-
Viropharma, Inc. (VPHM) Tops Q3 EPS by 15c; Updates Outlook
-
Trading Radar for 10/31: Alcatel (ALU), First Solar (FSLR), ConocoPhillips (COP), Oshkosh (OSK) Report
-
Trading Radar for 10/28: Apple (AAPL), Seagate (STX), Herbalife (HLF), Crane (CR) Report
-
Trading Radar for 10/24: Microsoft (MSFT), Hershey (HSY), Western DIgital (WDC), Potash Corp (POT), Under Armour (UA) Report
-
Notable Analyst Rating Changes 10/09: (MAS) (MCK) (EOG) Upgraded; (GDOT) (VPHM) (MAN) Downgraded
-
Mizuho Securities Downgrades ViroPharma (VPHM) to Neutral
-
ViroPharma (VPHM) Could Draw 50% Premium in Takeover
-
Notable Analyst Rating Changes 09/19: (OSUR) (HUN) (GTAT) Upgraded; (GIS) (BPOP) (DPS) Downgraded
-
Deutsche Bank Cuts ViroPharma (VPHM) to Hold; Takeout Premium Reflected in Price
-
ViroPharma (VPHM) Target Raised to $30 at Goldman; Traders Buzz About M&A
-
Notable Analyst Rating Changes 09/18: (CTSH) (WFT) (NOK) Upgraded; (VPHM) (TWGP) (NRG) Downgraded
-
UPDATE: BofA/Merrill Lynch Downgrades ViroPharma (VPHM) to Underperform
-
Pre-Open Stock Movers 9/18: (ATOS) (AFOP) (ADBE) Higher; (SGMO) (FIVE) (FLTX) Lower (more...)
-
Notable 50-Day SMA Crossers 09/13: (MSFT) (VPHM) (STP) Above; (GE) (SWN) (COV) Below
-
ViroPharma (VPHM) Fair Value $46-$52 in M&A Scenarios - Deutsche Bank
-
Wells Fargo Downgrades ViroPharma (VPHM) to Market Perform
-
BioCryst Pharma (BCRX) Rally Tied to ViroPharma (VPHM) Rumors
-
UPDATE: ViroPharma Inc. (VPHM) Hires Goldman to Explore Sale - Bloomberg
-
BofA/Merrill Lynch Downgrades ViroPharma (VPHM) to Neutral
-
Unusual 11 Mid-Day Movers 08/01: (SR) (QLKS) (ZLTQ) Higher; (MDCI) (MDCI) (STXS) (HALO) Lower
-
Streetinsider.com Pre-Open Movers 08/01: (BCRX) (CTRP) (TRLA) Higher; (ENTR) (HALO) (BGFV) Lower (more...)
-
Viropharma, Inc. (VPHM) Tops Q2 EPS by 14c
-
Halozyme (HALO) Affirms Discontinuation of Cinryze Phase 2 in rHuPH20 (VPHM)
-
Viropharma (VPHM) to Discontinue Cinryze Phase 2 on Recombinant Human Hyaluronidase (rHuPH20)
-
Trading Radar for 08/01: Exxon (XOM), Chesapeake (CHK), P&G (PG), Activision (ATVI) Report
-
BioCryst's (BCRX) BCX4161 Too Early to Threaten ViroPharma's (VPHM) Cinryze
-
Brean Capital Assumes/Upgrades ViroPharma (VPHM) to Buy
-
Jefferies Reiterates Bullish View on ViroPharma (VPHM)
-
Deutsche Bank Notes Positive Data for ViroPharma's (VPHM) Maribavir
-
Oppenheimer Starts ViroPharma (VPHM) at Outperform
-
UPDATE: Viropharma, Inc. (VPHM) Said to Attract Acquisition Interest - Reuters
Back to VPHM Stock Lookup